Literature DB >> 31687268

Recent advances in the genetics of frontotemporal dementia.

Daniel W Sirkis1, Ethan G Geier1, Luke W Bonham1, Celeste M Karch2, Jennifer S Yokoyama1.   

Abstract

PURPOSE OF REVIEW: In this review we highlight recent advances in the human genetics of frontotemporal dementia (FTD). In addition to providing a broad survey of genes implicated in FTD in the last several years, we also discuss variation in genes implicated in both hereditary leukodystrophies and risk for FTD (e.g., TREM2, TMEM106B, CSF1R, AARS2, NOTCH3). RECENT
FINDINGS: Over the past five years, genetic variation in approximately 50 genes has been confirmed or suggested to cause or influence risk for FTD and FTD-spectrum disorders. We first give background and discuss recent findings related to C9ORF72, GRN and MAPT, the genes most commonly implicated in FTD. We then provide a broad overview of other FTD-associated genes and go on to discuss new findings in FTD genetics in East Asian populations, including pathogenic variation in CHCHD10, which may represent a frequent cause of disease in Chinese populations. Finally, we consider recent insights gleaned from genome-wide association and genetic pleiotropy studies.
SUMMARY: Recent genetic discoveries highlight cellular pathways involving autophagy, the endolysosomal system and neuroinflammation, and reveal an intriguing overlap between genes that confer risk for leukodystrophy and FTD.

Entities:  

Keywords:  autophagy; frontotemporal lobar degeneration; genetics; inflammation; leukodystrophy; lysosomes

Year:  2019        PMID: 31687268      PMCID: PMC6827567          DOI: 10.1007/s40142-019-0160-6

Source DB:  PubMed          Journal:  Curr Genet Med Rep        ISSN: 2167-4876


  118 in total

1.  High prevalence of CHCHD10 mutation in patients with frontotemporal dementia from China.

Authors:  Bin Jiao; Tingting Xiao; Lihua Hou; Xiaohua Gu; Yafang Zhou; Lin Zhou; Beisha Tang; Jun Xu; Lu Shen
Journal:  Brain       Date:  2015-12-30       Impact factor: 13.501

2.  Tau is a candidate gene for chromosome 17 frontotemporal dementia.

Authors:  P Poorkaj; T D Bird; E Wijsman; E Nemens; R M Garruto; L Anderson; A Andreadis; W C Wiederholt; M Raskind; G D Schellenberg
Journal:  Ann Neurol       Date:  1998-06       Impact factor: 10.422

3.  TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration.

Authors:  Lina Benajiba; Isabelle Le Ber; Agnès Camuzat; Mathieu Lacoste; Catherine Thomas-Anterion; Philippe Couratier; Solenn Legallic; François Salachas; Didier Hannequin; Marielle Decousus; Lucette Lacomblez; Eric Guedj; Véronique Golfier; William Camu; Bruno Dubois; Dominique Campion; Vincent Meininger; Alexis Brice
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

4.  Mutations in TREM2 lead to pure early-onset dementia without bone cysts.

Authors:  Eliane Chouery; Valérie Delague; Anne Bergougnoux; Salam Koussa; Jean-Louis Serre; André Mégarbané
Journal:  Hum Mutat       Date:  2008-09       Impact factor: 4.878

Review 5.  Modifiers of GRN-Associated Frontotemporal Lobar Degeneration.

Authors:  Eline Wauters; Sara Van Mossevelde; Julie Van der Zee; Marc Cruts; Christine Van Broeckhoven
Journal:  Trends Mol Med       Date:  2017-09-07       Impact factor: 11.951

6.  Analyses MAPT, GRN, and C9orf72 mutations in Chinese patients with frontotemporal dementia.

Authors:  Min Tang; Xiaohua Gu; Jingya Wei; Bin Jiao; Lin Zhou; Yafang Zhou; Ling Weng; Xinxiang Yan; Beisha Tang; Jun Xu; Lu Shen
Journal:  Neurobiol Aging       Date:  2016-05-20       Impact factor: 4.673

7.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

8.  Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.

Authors:  Han-Xiang Deng; Wenjie Chen; Seong-Tshool Hong; Kym M Boycott; George H Gorrie; Nailah Siddique; Yi Yang; Faisal Fecto; Yong Shi; Hong Zhai; Hujun Jiang; Makito Hirano; Evadnie Rampersaud; Gerard H Jansen; Sandra Donkervoort; Eileen H Bigio; Benjamin R Brooks; Kaouther Ajroud; Robert L Sufit; Jonathan L Haines; Enrico Mugnaini; Margaret A Pericak-Vance; Teepu Siddique
Journal:  Nature       Date:  2011-08-21       Impact factor: 49.962

9.  A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers.

Authors:  Ming Zhang; Raffaele Ferrari; Maria Carmela Tartaglia; Julia Keith; Ezequiel I Surace; Uri Wolf; Christine Sato; Mark Grinberg; Yan Liang; Zhengrui Xi; Kyle Dupont; Philip McGoldrick; Anna Weichert; Paul M McKeever; Raphael Schneider; Michael D McCorkindale; Claudia Manzoni; Rosa Rademakers; Neill R Graff-Radford; Dennis W Dickson; Joseph E Parisi; Bradley F Boeve; Ronald C Petersen; Bruce L Miller; William W Seeley; John C van Swieten; Jeroen van Rooij; Yolande Pijnenburg; Julie van der Zee; Christine Van Broeckhoven; Isabelle Le Ber; Vivianna Van Deerlin; EunRan Suh; Jonathan D Rohrer; Simon Mead; Caroline Graff; Linn Öijerstedt; Stuart Pickering-Brown; Sara Rollinson; Giacomina Rossi; Fabrizio Tagliavini; William S Brooks; Carol Dobson-Stone; Glenda M Halliday; John R Hodges; Olivier Piguet; Giuliano Binetti; Luisa Benussi; Roberta Ghidoni; Benedetta Nacmias; Sandro Sorbi; Amalia C Bruni; Daniela Galimberti; Elio Scarpini; Innocenzo Rainero; Elisa Rubino; Jordi Clarimon; Alberto Lleó; Agustin Ruiz; Isabel Hernández; Pau Pastor; Monica Diez-Fairen; Barbara Borroni; Florence Pasquier; Vincent Deramecourt; Thibaud Lebouvier; Robert Perneczky; Janine Diehl-Schmid; Jordan Grafman; Edward D Huey; Richard Mayeux; Michael A Nalls; Dena Hernandez; Andrew Singleton; Parastoo Momeni; Zhen Zeng; John Hardy; Janice Robertson; Lorne Zinman; Ekaterina Rogaeva
Journal:  Brain       Date:  2018-10-01       Impact factor: 13.501

10.  Mutated CTSF in adult-onset neuronal ceroid lipofuscinosis and FTD.

Authors:  Julie van der Zee; Peter Mariën; Roeland Crols; Sara Van Mossevelde; Lubina Dillen; Federica Perrone; Sebastiaan Engelborghs; Jo Verhoeven; Tine D'aes; Chantal Ceuterick-De Groote; Anne Sieben; Jan Versijpt; Patrick Cras; Jean-Jacques Martin; Christine Van Broeckhoven
Journal:  Neurol Genet       Date:  2016-09-16
View more
  12 in total

Review 1.  How understudied populations have contributed to our understanding of Alzheimer's disease genetics.

Authors:  Nadia Dehghani; Jose Bras; Rita Guerreiro
Journal:  Brain       Date:  2021-05-07       Impact factor: 13.501

Review 2.  Clinical and Neuroimaging Aspects of Familial Frontotemporal Lobar Degeneration Associated with MAPT and GRN Mutations.

Authors:  Bradley F Boeve; Howard Rosen
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Recovery of Depleted miR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons.

Authors:  Marta Barbosa; Cátia Gomes; Catarina Sequeira; Joana Gonçalves-Ribeiro; Carolina Campos Pina; Luís A Carvalho; Rui Moreira; Sandra H Vaz; Ana Rita Vaz; Dora Brites
Journal:  Front Cell Dev Biol       Date:  2021-04-23

Review 4.  Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Jessica Root; Paola Merino; Austin Nuckols; Michelle Johnson; Thomas Kukar
Journal:  Neurobiol Dis       Date:  2021-03-31       Impact factor: 7.046

Review 5.  The Role of Microglia in Inherited White-Matter Disorders and Connections to Frontotemporal Dementia.

Authors:  Daniel W Sirkis; Luke W Bonham; Jennifer S Yokoyama
Journal:  Appl Clin Genet       Date:  2021-03-31

6.  The Frequency of Genetic Mutations Associated With Behavioral Variant Frontotemporal Dementia in Chinese Han Patients.

Authors:  Li Liu; Bo Cui; Min Chu; Yue Cui; Donglai Jing; Dan Li; Kexin Xie; Yu Kong; Tianxinyu Xia; Chaodong Wang; Liyong Wu
Journal:  Front Aging Neurosci       Date:  2021-07-08       Impact factor: 5.750

Review 7.  Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.

Authors:  Ramya Ranganathan; Shaila Haque; Kayesha Coley; Stephanie Shepheard; Johnathan Cooper-Knock; Janine Kirby
Journal:  Front Neurosci       Date:  2020-07-07       Impact factor: 4.677

Review 8.  From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline.

Authors:  Rajka Maria Liscic; Antonella Alberici; Nigel John Cairns; Maurizio Romano; Emanuele Buratti
Journal:  Mol Neurodegener       Date:  2020-06-01       Impact factor: 14.195

Review 9.  The Role of White Matter Dysfunction and Leukoencephalopathy/Leukodystrophy Genes in the Aetiology of Frontotemporal Dementias: Implications for Novel Approaches to Therapeutics.

Authors:  Hiu Chuen Lok; John B Kwok
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

10.  Aged Tmem106b knockout mice display gait deficits in coincidence with Purkinje cell loss and only limited signs of non-motor dysfunction.

Authors:  Stijn Stroobants; Rudi D'Hooge; Markus Damme
Journal:  Brain Pathol       Date:  2020-11-01       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.